吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, May 31 2018

Full Issue

Trump Signs 'Right-To-Try' Law, Saying It Gives Patients 'Fundamental Freedom' To Get Experimental Drugs

President Donald Trump says he never understood why the issue had lagged for years, but some Democrats and public health advocates fear that the measure offers patients "false hope."

President Donald Trump signed legislation Wednesday aimed at helping people with deadly diseases try experimental treatments, calling it a 鈥渇undamental freedom鈥 that will offer hope and save lives. Joined by families dealing with amyotrophic lateral sclerosis, also called Lou Gehrig鈥檚 disease, and other diseases, Trump signed the so-called Right to Try bill and said he never understood why the issue had lagged for years and Congress hadn鈥檛 acted sooner. (Thomas, 5/30)

Most Democrats and public health groups oppose the bill, arguing that it could put patients in danger. 鈥淔DA oversight of access to experimental treatments exists for a reason 鈥 it protects patients from potential snake oil salesmen or from experimental treatments that might do more harm than good,鈥 said Rep. Frank Pallone Jr. (D-N.J.), ranking member of the House Energy and Commerce Committee. (Hellmann, 5/30)

President Trump claimed that a new law allowing access to experimental drugs would save 鈥渉undreds of thousands鈥 of lives. But there is already a federal program in place, and similar state laws have had a minimal effect. (Qiu, 5/30)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, August 6
  • Wednesday, August 5
  • Tuesday, August 4
  • Monday, August 3
  • Friday, July 31
  • Thursday, July 30
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF